[go: up one dir, main page]

UY30111A1 - Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida - Google Patents

Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida

Info

Publication number
UY30111A1
UY30111A1 UY30111A UY30111A UY30111A1 UY 30111 A1 UY30111 A1 UY 30111A1 UY 30111 A UY30111 A UY 30111A UY 30111 A UY30111 A UY 30111A UY 30111 A1 UY30111 A1 UY 30111A1
Authority
UY
Uruguay
Prior art keywords
salts
carboxamide
oxo
addition salts
trifluormetil
Prior art date
Application number
UY30111A
Other languages
English (en)
Inventor
Amedeo Leonardi
Gianni Motta
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of UY30111A1 publication Critical patent/UY30111A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencinn provee sales de adicinn e N-3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifuormetil-7H-tieno(3,2-b)piran-3-carboxamida con rcidos inorgrnicos, sulfnnicos o carboxelicos. Las sales preferidas son aquellas formadas con rcidos clorhedrico, bromhedrico, metansulfnnico, bencensulfnnico, toluensulfnnico o naftalen-1,5-disulfnnico. Es aun mrs prferida una sal mesilato cristalina en una forma polimnrfica unica. Las sales de la invencinn son con preferencia al menos 95% puras, conteniendo las impurezas no mrs de 2% en peso del total del subproducto N-(3-4-(2-metoxifenil)-1-piperazinil)-propil)-4-hidroxi-5-((Z)-4,4,4-trifluor-3-hidroxi-2-butenoil)-tiofen-3-carboxamida. Tambicn se proveen composiciones farmaccutias que contienen las sales de la invencinn. Las sales de la invencinn y las composiciones farmaccuticas que las contienen son utiles para el tratamiento de sendromes obstructivos del tracto urinario inferior, que incluyen HPB.
UY30111A 2006-02-03 2007-01-25 Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida UY30111A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76482406P 2006-02-03 2006-02-03

Publications (1)

Publication Number Publication Date
UY30111A1 true UY30111A1 (es) 2007-04-30

Family

ID=37983328

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30111A UY30111A1 (es) 2006-02-03 2007-01-25 Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida

Country Status (6)

Country Link
US (1) US20070185129A1 (es)
AR (1) AR059302A1 (es)
PE (1) PE20070950A1 (es)
TW (1) TW200804395A (es)
UY (1) UY30111A1 (es)
WO (1) WO2007088063A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2231152B1 (en) * 2008-01-24 2014-01-01 SignalRX Pharmaceuticals, Inc. Thienopyranones as kinase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306861B1 (en) * 1999-07-30 2001-10-23 Recordati S.A. Chemical And Pharmaceutical Company Thienopyrancecarboxamide derivatives
US6387909B1 (en) * 1999-07-30 2002-05-14 Recordati S.A. Chemical And Pharmaceutical Company Thienopyranecarboxamide derivatives
IT1313581B1 (it) * 1999-07-30 2002-09-09 Recordati Chem Pharm Derivati tienopirancarbossamidici.
TWI265925B (en) * 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
ITMI20010164A1 (it) * 2001-01-30 2002-07-30 Recordati Chem Pharm Alfa 1 antagonisti selettivi a + d
EP1401835A1 (en) * 2001-06-05 2004-03-31 Lilly Icos LLC Carboline derivatives as pde-5 inhibitors

Also Published As

Publication number Publication date
AR059302A1 (es) 2008-03-26
WO2007088063A1 (en) 2007-08-09
TW200804395A (en) 2008-01-16
US20070185129A1 (en) 2007-08-09
PE20070950A1 (es) 2007-09-10

Similar Documents

Publication Publication Date Title
ES2511942T3 (es) Análogos de cromenona como moduladores de sirtuina
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
ES2351110T3 (es) Compuestos de piperidinilamino-tieno[2,3-d]-pirimidina.
PE20080186A1 (es) Derivados 4,6-disustituidos de 2-metoxi-6-etilamino-pirimidina como antagonistas del receptor de prostaglandina d2
CY1112011T1 (el) Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
CR7496A (es) Piridinoilpiperidinas como agonistas de 5- ht1f
PE20060748A1 (es) Derivados de indolcarboxamida como inhibidores de quinasa ikk2
CY1117974T1 (el) ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΚΥΚΛΟΠΕΝΤΑ[b]ΙΝΔΟΛ-3-ΥΛ-ΟΞΙΚΟΥ ΟΞΕΟΣ ΧΡΗΣΙΜΑ ΣΤΗΝ ΑΓΩΓΗ ΑΥΤΟΑΝΟΣΩΝ ΚΑΙ ΦΛΕΓΜΟΝΩΔΩΝ ΔΙΑΤΑΡΑΧΩΝ
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
ATE478058T3 (de) 3,7-diamino-10h-phenothiazinsalze und ihre verwendung
ECSP055615A (es) Nuevos compuestos de amida de ácido carboxílico con efecto antagónico de la hcm, medicamentos que contienen estos compuestos y procedimientos para su preparación
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
NO20073957L (no) Farmasoytiske forbindelser
GB0510584D0 (en) Organic compounds
WO2009013348A3 (en) Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
NO20091782L (no) Fremgangsmate for syntese av derivater av 3-amino-tetrahydrofuran-3-karboxylsyre og deres anvendelse som medikamenter
CY1113257T1 (el) Παραγωγα βενζυλοπιπεραζινης τα οποια ειναι χρησιμα στη θεραπεια γαστρεντερικων διαταραχων
GT200500281A (es) Compuestos organicos.
DE602007011434D1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
Kus et al. Synthesis and antimicrobial activity of some novel 2‐[4‐(substituted piperazin‐/piperidin‐1‐ylcarbonyl) phenyl]‐1H‐benzimidazole derivatives
ATE495159T1 (de) Diaminocyclohexan- und diaminocyclopentanderivate
UY30111A1 (es) Sales de adicion de acido de n-(3-(4-(2-metoxifenil)-1-piperazinil)-propil)-7-oxo-5-trifluormetil-7h-tieno (3,2-b) piran-3-carboxamida
DK1751093T3 (da) Substituerede cyklohexyleddikesyre-derivater
UA97957C2 (ru) 2-{5-фтор-2-метил-3-[2-(фенилсульфонил)бензил]-1н-индол-1-ил}уксусная кислота и ее производные, их применение для лечения заболеваний, опосредствованных действием pgd2 на рецептор crth2